These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20521250)

  • 1. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.
    Wu WK; Wang G; Coffelt SB; Betancourt AM; Lee CW; Fan D; Wu K; Yu J; Sung JJ; Cho CH
    Int J Cancer; 2010 Oct; 127(8):1741-7. PubMed ID: 20521250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
    Sun L; Wang W; Xiao W; Yang H
    Inflamm Bowel Dis; 2016 Aug; 22(8):1986-91. PubMed ID: 27135484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cathelicidin LL-37 in Cancer Development.
    Piktel E; Niemirowicz K; Wnorowska U; Wątek M; Wollny T; Głuszek K; Góźdź S; Levental I; Bucki R
    Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):33-46. PubMed ID: 26395996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
    Fahy RJ; Wewers MD
    Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the multifunctional peptide LL-37 in host defense.
    Kai-Larsen Y; Agerberth B
    Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.
    Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE
    J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
    Nijnik A; Hancock RE
    Curr Opin Hematol; 2009 Jan; 16(1):41-7. PubMed ID: 19068548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide.
    Golec M
    Ann Agric Environ Med; 2007; 14(1):1-4. PubMed ID: 17655171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.
    von Haussen J; Koczulla R; Shaykhiev R; Herr C; Pinkenburg O; Reimer D; Wiewrodt R; Biesterfeld S; Aigner A; Czubayko F; Bals R
    Lung Cancer; 2008 Jan; 59(1):12-23. PubMed ID: 17764778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways.
    Yu J; Mookherjee N; Wee K; Bowdish DM; Pistolic J; Li Y; Rehaume L; Hancock RE
    J Immunol; 2007 Dec; 179(11):7684-91. PubMed ID: 18025214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
    Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
    Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
    Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
    Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular receptor for human host defense peptide LL-37 in monocytes.
    Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
    J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer.
    Ren SX; Cheng AS; To KF; Tong JH; Li MS; Shen J; Wong CC; Zhang L; Chan RL; Wang XJ; Ng SS; Chiu LC; Marquez VE; Gallo RL; Chan FK; Yu J; Sung JJ; Wu WK; Cho CH
    Cancer Res; 2012 Dec; 72(24):6512-23. PubMed ID: 23100468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
    Wang G
    J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
    Nagaoka I; Tamura H; Hirata M
    J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
    Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
    J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.